搜尋結果
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
斯他汀類降血脂藥物,哪款藥物在治療冠心病患者上更勝一籌?
KingNet 國家網路醫藥 via Yahoo奇摩新聞· 5 個月前作者/張中維藥師冠心症,也稱為冠狀動脈疾病,是一種由於冠狀動脈受損或阻塞而引起的心臟疾病。冠狀動 ...
Can Genomics Stop the World's Leading Cause of Death?
ACCESSWIRE· 2 年前For decades, cardiovascular disease has remained the number-one cause of death. In 2019 alone, ...
In Case of Emergency: Plans to Prepare Your Business for the Unknown
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / October 26, 2022 / Antea Group: Preparing for the unknown as a ...